ArticleBMC musculoskeletal disorders2025
Autograft bone grafting via surgical hip dislocation for collapsed necrotic femoral head: a mid-term retrospective study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Robot-assisted versus traditional core decompression combined with human umbilical cord-derived mesenchymal stem cell transplantation for osteonecrosis of the femoral head: A retrospective cohort study.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the mid-term outcomes of surgical hip dislocation combined with bone graft impacting and non-vascularized iliac crest bone flap implanting in the treatment of post-collapse osteonecrosis of femoral head (ONFH).
methodsFrom October 2014 and April 2020, 111 patients (121 hips) with ONFH were retrospectively reviewed. Assessment parameters included the Visual analog scale (VAS) pain scores and Harris hip score (HHS). Follow-up end points were set as total hip arthroplasty (THA). Conversion to THA was selected as the definitive endpoint, representing an objective clinical failure requiring intervention, whereas radiologic re-collapse lacks standardized definition and may not consistently correlate with symptomatic progression or necessitate revision surgery. Therefore, it was not used in this study. Kaplan–Meier survival analysis was used to examine the survival rate. Multivariate Cox regression analysis was used to investigate the risk factors associated with conversion to THA, including age, etiology, duration of pain, combined preserved angle (CPA), and hip joint medial space ratio (MSR). Pre- and postoperative variables of HHS in the different groups were assessed.
resultsThe average follow-up time was 53.82 ± 25.36 months. The mean VAS score and HHS were significantly improved at the final follow-up compared with preoperative values (p < 0.001). By the time of the last follow-up, 19 hips failed and reached the end point of observation. The overall survival rate was 84.30% at 60 months. Multivariate Cox regression analysis revealed that CPA and MSR were independent factor associated with conversion to THA. These findings establish CPA and MSR as crucial preoperative prognostic indicators and patient selection tools. Clinical outcomes was affected by age, duration of pain, JIC classification, combined preserved angle (CPA), and hip joint medial space ratio (MSR).
conclusionsSurgical hip dislocation combined with non-vascularized iliac crest bone flap bone grafting is an effective treatment on post-collapse ONFH with satisfactory mid-term results, particularly when patients are selected based on favorable preoperative CPA (> 118.73°) and MSR (≤ 20.35%) values. Multicenter studies with longer follow-up are needed to further validate the efficacy of this procedure in post-collapse ONFH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.